银城国际控股(01902.HK)拟3.35亿元收购南京东方颐年健康产业余下25%股权
格隆汇2月4日丨银城国际控股(01902.HK)发布公告,于2021年2月4日,买方南京银城房地产开发有限公司(公司的间接全资附属公司)与卖方江苏瑞华投资控股集团有限公司订立该协议,买方同意收购目标公司南京东方颐年健康产业发展有限公司25%股权,代价为人民币3.35亿元。
目标公司为根据中国法律成立的有限公司,主要从事养老物业发展以及投资及管理医院。目标公司的主要资产为住宅物业以及其为长者开发的配套保健设施。
完成登记将目标股权转至买方名下后,目标公司将成为公司的间接全资附属公司。董事会认为,收购事项将让集团全面控制目标公司的营运,以确保专为长者而设的住宅物业发展的效率及高产品质素。此外,由于目标公司的业务营运符合集团整体发展目标,董事会认为,收购事项可策略性巩固集团于中国养老物业市场的版图及地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.